血栓性微血管病与抗血管内皮生长因子药物 - Suppr

Suppr

超能文献

Thrombotic microangiopathy and anti-VEGF agents.

作者信息

Izzedine Hassane, Brocheriou Isabelle, Deray Gilbert, Rixe Olivier

出版信息

Nephrol Dial Transplant. 2007 May;22(5):1481-2. doi: 10.1093/ndt/gfl565. Epub 2006 Dec 21.

DOI:10.1093/ndt/gfl565

PMID:17189283

Abstract

摘要

相似文献

Thrombotic microangiopathy and anti-VEGF agents.

Nephrol Dial Transplant. 2007 May;22(5):1481-2. doi: 10.1093/ndt/gfl565. Epub 2006 Dec 21.

VEGF inhibition and renal thrombotic microangiopathy.

N Engl J Med. 2008 Jul 10;359(2):206; author reply 206-7.

VEGF inhibition and renal thrombotic microangiopathy.

N Engl J Med. 2008 Jul 10;359(2):205-6; author reply 206-7. doi: 10.1056/NEJMc080770.

VEGF inhibition and renal thrombotic microangiopathy.

N Engl J Med. 2008 Mar 13;358(11):1129-36. doi: 10.1056/NEJMoa0707330.

Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.

Kidney Int. 2001 Oct;60(4):1297-308. doi: 10.1046/j.1523-1755.2001.00935.x.

VEGF Trap for the treatment of malignant ascites.

Lancet Oncol. 2012 Feb;13(2):115-6. doi: 10.1016/S1470-2045(11)70394-1. Epub 2011 Dec 20.

Vascular endothelial growth factor receptors: expression and function in solid tumors.

Clin Adv Hematol Oncol. 2004 Jan;2(1):37-45.

The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy.

Pediatr Nephrol. 1999 Sep;13(7):564-6. doi: 10.1007/s004670050743.

The role of vascular endothelial growth factor in restenosis: the controversy continues.

Circulation. 2004 Oct 19;110(16):2283-6. doi: 10.1161/01.CIR.0000146723.23523.47.

Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.

Lancet Oncol. 2007 Feb;8(2):177-8. doi: 10.1016/S1470-2045(07)70037-2.

引用本文的文献

Evidence-Based Guidelines for Intravitreal Anti-VEGF Therapy for Diabetic Retinopathy in Chronic Kidney Disease.

Diabetes Ther. 2025 Sep 11. doi: 10.1007/s13300-025-01791-y.

Chronic thrombotic microangiopathy presenting as acute nephrotic syndrome in a patient with renal cancer receiving tyrosine kinase inhibitor therapy.

BMJ Case Rep. 2024 Jan 5;17(1):e255841. doi: 10.1136/bcr-2023-255841.

Thrombotic Microangiopathy in the Setting of Colorectal Cancer: A Therapeutic Challenge with a Bad Prognosis.

Hematol Rep. 2023 Jan 4;15(1):9-16. doi: 10.3390/hematolrep15010002.

Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugs.

Biomed Rep. 2022 Jun;16(6):46. doi: 10.3892/br.2022.1529. Epub 2022 Apr 7.

Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration.

Clin Kidney J. 2021 Mar 23;14(10):2158-2165. doi: 10.1093/ckj/sfab066. eCollection 2021 Oct.

Maternal microvascular dysfunction during preeclamptic pregnancy.

Clin Sci (Lond). 2021 May 14;135(9):1083-1101. doi: 10.1042/CS20200894.

Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.

Pediatr Nephrol. 2021 Aug;36(8):2227-2255. doi: 10.1007/s00467-020-04800-3. Epub 2020 Nov 27.

Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use.

Front Med (Lausanne). 2020 Oct 7;7:579603. doi: 10.3389/fmed.2020.579603. eCollection 2020.

Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed.

BMC Cancer. 2017 Nov 16;17(1):770. doi: 10.1186/s12885-017-3705-7.

Cancer-associated thrombotic microangiopathy.

Ecancermedicalscience. 2016 Jun 28;10:649. doi: 10.3332/ecancer.2016.649. eCollection 2016.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验